Crossmark

Deoxycytidine-kinase knockdown as a novel myeloprotective strategy in the context of fludarabine, cytarabine or cladribine therapy

Published Online: 2015-04-29

Published Print: 2015-11

Authors

Lachmann, N

Czarnecki, K

Brennig, S

Phaltane, R

Heise, M

Heinz, N

Kempf, H

Dilloo, D

Kaever, V

Schambach, A

Heuser, M

Moritz, T
License Information

Text and Data Mining valid from 2015-04-29

Version of Record valid from 2015-04-29
More Information

Article History

First Online: 29 April 2015

Competing interests

: The authors declare no conflict of interest.

Document is current